Feed excerpt — reported by Science Daily
Researchers at UC Berkeley have identified a compound that could transform weight-loss treatment by helping the body burn more energy instead of suppressing appetite like Ozempic and Wegovy. In mice, the compound boosted energy expenditure by up to 18%, improved blood sugar control, reduced liver fat, and promoted weight loss without significant muscle loss. Even more promising, combining it with existing GLP-1 medications produced greater benefits than either treatment alone.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Science Daily →